3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
22
Breast Neoplasms
21
Neoplasms
10
Brain Neoplasms
10
Glioma
8
Head and Neck Neoplasms
7
Lymphoma
6
Colonic Neoplasms
6
Urinary Bladder Neoplasms
5
Rectal Neoplasms
5
Pancreatic Neoplasms
5
Lymphoma, Non-Hodgkin
5
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Glioblastoma
4
Carcinoma, Hepatocellular
4
Astrocytoma
4
Squamous Cell Carcinoma of Head and Neck
3
Spinal Cord Neoplasms
3
Lung Neoplasms
3
Stomach Neoplasms
2
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Oligodendroglioma
2
Neurofibromatosis 1
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Meningioma
2
Lymphoma, B-Cell
2
Liver Neoplasms
2
Interventions
Carboplatin
7
Trastuzumab
6
Docetaxel
5
pembrolizumab
4
Paclitaxel
4
Oxaliplatin
4
Fluorouracil
4
Cytarabine
4
Cyclophosphamide
4
Azacitidine
4
pertuzumab
3
Radiotherapy
3
Epirubicin
3
Cisplatin
3
Chemoradiotherapy
3
Capecitabine
3
venetoclax
2
toripalimab
2
sargramostim
2
olaparib
2
durvalumab
2
cc-486
2
Tretinoin
2
Surgical Procedures, Operative
2
Standard of Care
2
Pemetrexed
2
Observation
2
Monatide (IMS 3015)
2
Metformin
2
Leucovorin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Pathologic Complete Response
×
Magnetic Resonance Imaging
×
Clear all
NCT07472868
2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3
Not yet recruiting
394 enrolled